American Heart Journal
Volume 149, Issue 5 , Pages 753-760 , May 2005

A critical appraisal of current models of risk stratification for percutaneous coronary interventions

  • Mandeep Singh, MD

      Affiliations

    • Division of Cardiovascular Diseases and Internal Medicine, Rochester, Minn
    • Corresponding Author InformationReprint requests: Dr Mandeep Singh, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
    • ,
  • Charanjit S. Rihal, MD

      Affiliations

    • Division of Cardiovascular Diseases and Internal Medicine, Rochester, Minn
    • ,
  • Ryan J. Lennon, MS

      Affiliations

    • Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minn
    • ,
  • Kirk N. Garratt, MD

      Affiliations

    • Division of Cardiovascular Diseases and Internal Medicine, Rochester, Minn
    • ,
  • David R. Holmes Jr., MD

      Affiliations

    • Division of Cardiovascular Diseases and Internal Medicine, Rochester, Minn

Received 26 October 2004 ,Accepted 17 January 2005.

References 

  1. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61–68
  2. Seshadri N, Whitlow PL, Acharya N, et al. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 2002;106:2346–2350
  3. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–634
  4. Rihal CS, Sutton-Tyrrell K, Guo P, et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation. 1999;100:171–177
  5. Singh M, Mathew V, Garratt KN, et al. Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med. 2000;108:187–192
  6. Takagi T, Stankovic G, Finci L, et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002;106:698–702
  7. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). Circulation. 1988;78:486–502
  8. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193–1202
  9. Ellis SG, Guetta V, Miller D, et al. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: an analysis of results from 10,907 lesions and proposal for new classification scheme. Circulation. 1999;100:1971–1976
  10. Krone RJ, Shaw RE, Klein LW, et al. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current “stent era” of coronary interventions (from the ACC-National Cardiovascular Data Registry). Am J Cardiol. 2003;92:389–394
  11. Block PC, Peterson ED, Krone R, et al. Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. J Am Coll Cardiol. 1998;32:275–282
  12. Kastrati A, Schomig A, Elezi S, et al. Prognostic value of the modified American College of Cardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation. 1999;100:1285–1290
  13. Zaacks SM, Allen JE, Calvin JE, et al. Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol. 1998;82:43–49
  14. Singh M, Rihal CS, Lennon RJ, et al. Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions. J Am Coll Cardiol. 2004;44:357–361
  15. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967;54:167–179
  16. Hocking RR. The analysis and selection of variables in linear regression variation of linear analysis. Biometrics. 1976;32:1–50
  17. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: Application to the Cox regression model. Stat Med. 1992;11:2093–2109
  18. Hosmer DWLS. A goodness-of-fit test for the multiple logistic regression model. Commun Stat. 1980;A10:1043–1069
  19. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
  21. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA. 1997;277:892–898
  22. Holmes DR, Berger PB, Garratt KN, et al. Application of the New York State PTCA mortality model in patients undergoing stent implantation. Circulation. 2000;102:517–522
  23. Shaw RE, Anderson HV, Brindis RG, et al. Development of a risk adjustment mortality model using the American College of Cardiology–National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol. 2002;39:1104–1112
  24. O'Connor GT, Malenka DJ, Quinton H, et al. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 1999;34:681–691
  25. Moscucci M, Kline-Rogers E, Share D, et al. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation. 2001;104:263–268
  26. Qureshi MA, Safian RD, Grines CL, et al. Simplified scoring system for predicting mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1890–1895
  27. Ellis SG, Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 1997;95:2479–2484
  28. Singh M, Lennon RJ, Holmes DR, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol. 2002;40:387–393
  29. Resnic FS, Ohno-Machado L, Selwyn A, et al. Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol. 2001;88:5–9
  30. Thiemann DR. Primary angioplasty for elderly patients with myocardial infarction: theory, practice and possibilities. J Am Coll Cardiol. 2002;39:1729–1732
  31. Juliard JM, Charlier P, Golmard JL, et al. Age and lack of beta-blocker therapy are associated with increased long-term mortality after primary coronary angioplasty for acute myocardial infarction. Int J Cardiol. 2003;88:63–68
  32. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1113–1119
  33. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264
  34. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol. 1999;34:1512–1521
  35. Gurm HS, Bhatt DL, Gupta R, et al. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J. 2003;146:692–698
  36. Lee PC, Kini AS, Ahsan C, et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44:541–546
  37. Malenka DJ, McGrath PD, Wennberg DE, et al. The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: the northern New England experience. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 1999;34:1471–1480
  38. Holmes DR, Selzer F, Johnston JM, et al. Modeling and risk prediction in the current era of interventional cardiology: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circulation. 2003;107:1871–1876
  39. Singh M, Rihal CS, Selzer F, et al. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute Dynamic Registry. J Am Coll Cardiol. 2003;42:1722–1728

PII: S0002-8703(05)00060-8

doi: 10.1016/j.ahj.2005.01.028

American Heart Journal
Volume 149, Issue 5 , Pages 753-760 , May 2005

Article Tools

* Image Usage & Resolution